Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification

2026-03-26 - 05:30

IdentiClone® Dx IGH is the first IVDR-certified assay for the detection of clonal immunoglobulin gene rearrangements in patients with suspected B-cell lymphoproliferative disease. Read More